BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9109497)

  • 1. Oncogene- and tumor-suppressor gene-related proteins in plants and fungi.
    Loidl A; Loidl P
    Crit Rev Oncog; 1996; 7(1-2):49-64. PubMed ID: 9109497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfur dioxide and benzo(a)pyrene modulates CYP1A and tumor-related gene expression in rat liver.
    Qin G; Meng Z
    Environ Toxicol; 2010 Apr; 25(2):169-79. PubMed ID: 19408242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes with potential nuclear function: myc, myb and fos.
    Eisenman RN; Thompson CB
    Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A; Samuel V; Forbes M
    J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell.
    Hall SH; Berthelon MC; Avallet O; Saez JM
    Endocrinology; 1991 Sep; 129(3):1243-9. PubMed ID: 1651842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mdm2 proto-oncogene.
    Haines DS
    Leuk Lymphoma; 1997 Jul; 26(3-4):227-38. PubMed ID: 9322885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
    Slack A; Chen Z; Tonelli R; Pule M; Hunt L; Pession A; Shohet JM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):731-6. PubMed ID: 15644444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
    Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
    Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells.
    Fang MZ; Mar W; Cho MH
    Toxicology; 2002 Aug; 177(2-3):253-65. PubMed ID: 12135628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cancer metabolism by oncogenes and tumor suppressors.
    Iurlaro R; León-Annicchiarico CL; Muñoz-Pinedo C
    Methods Enzymol; 2014; 542():59-80. PubMed ID: 24862260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oncogene and tumor suppressor gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasia.
    Sunday ME; Willett CG; Patidar K; Graham SA
    Lab Invest; 1994 Jun; 70(6):875-88. PubMed ID: 8015292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines.
    Isfort RJ; Cody DB; Lovell G; Doersen CJ
    Mol Carcinog; 1995 Nov; 14(3):170-8. PubMed ID: 7576109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
    Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
    Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.